Biologic Therapies for Severe Asthma with Type 2 Inflammation: Current Evidence, Patient Selection, and Future Perspectives

Puntos clave

• This research evaluates the effectiveness of biologic therapies in treating severe asthma with type 2 inflammation and identifies factors for optimal patient selection.
• Review of current literature on biologic agents for allergic asthma.
• Analysis of personalized medicine approaches for treatment
• Assessment of patient selection criteria and disparities.
• Biologic therapies show significant clinical benefits in patients with type 2 inflammation.
• Personalized medicine enhances treatment efficacy and improves patient outcomes.
• Further research is needed to refine patient selection and expand therapeutic strategies.